Gilead Sciences (GILD) Assets Average (2009 - 2026)

Gilead Sciences (GILD) has reported Assets Average for 18 consecutive years, with $52.8 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 5.81% year-over-year to $52.8 billion; the trailing twelve-month figure through Jun 2026 stood at $52.8 billion (down 5.81% YoY), and the FY2025 full-year result was $59.0 billion, down 2.56% from the prior year.
• Assets Average retreated to $52.8 billion in Q2 2026 per GILD's latest filing, from $57.7 billion in the prior quarter.
• Across five years, Assets Average topped out at $65.5 billion in Q1 2022 and bottomed at $52.8 billion in Q2 2026.
• Historically, Assets Average has averaged $59.4 billion across 5 years, with a median of $59.0 billion in 2024.
• The sharpest annual moves came in 2024 and 2025: Assets Average slipped 13.32% in 2024, then rose 5.69% in 2025.
• Over 5 years, Assets Average stood at $62.9 billion in 2022, then slipped by 0.98% to $62.2 billion in 2023, then declined by 8.82% to $56.8 billion in 2024, then gained by 3.56% to $58.8 billion in 2025, then dropped by 10.14% to $52.8 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $52.8 billion, $57.7 billion, and $58.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.